Exclusive: Dicerna CEO Talks Goals For 2017, Competitors And Prospects Under Trump
February 22, 2017 at 14:36 PM EST
Benzinga recently had the opportunity to pick the brain of Dicerna Pharmaceuticals Inc (NASDAQ: DRNA) CEO Douglas M. Fambrough, ...
